InvestorsHub Logo
Followers 480
Posts 60396
Boards Moderated 18
Alias Born 09/20/2001

Re: None

Tuesday, 07/16/2019 12:57:23 AM

Tuesday, July 16, 2019 12:57:23 AM

Post# of 10460
CNS therapy on the cellular level.

Anavex 2-73 is running six trials world wide on three different CNS diseases - Alzheimer's, Parkinson's Dementia, and Rett Syndrome.

Anavex 2-73 restores cellular homeostasis throughout the body and may be able to impact diseases of aging beyond CNS, such as high blood pressure, stroke, and more.

The DD produced on the Anavex board is so comprehensive that I've had to organise it into a compilation as best I can. Yes, the compilation could be better organized, but the information is coming in faster that I can organize it.

This is the current compiled DD post. Before getting into the main post too deeply you may wish to go to the bottom of the post where the DD is broken into sub posts that go more deeply into the science.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149887831



In Peace, In War

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.